Product
6 cycles chemotherapy
2 clinical trials
5 indications
Indication
RetinoblastomaIndication
Ovarian CancerIndication
Fallopian tube cancerIndication
Primary Peritoneal CarcinomaIndication
Clear Cell CarcinomaClinical trial
Three Cycles Versus Six Cycles of Adjuvant Chemotherapy for the Patients With High-risk Retinoblastoma After Enucleation: Prospective Randomized Control StudyStatus: Active (not recruiting), Estimated PCD: 2024-04-01
Clinical trial
A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy (N-Plus)Status: Not yet recruiting, Estimated PCD: 2027-05-01